Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 22

1.

Anthropometric measurements and lipid profiles to detect early lipodystrophy in antiretroviral therapy experienced HIV-infected children in the CHAPAS-3 trial.

Musiime V, Cook A, Kayiwa J, Zangata D, Nansubuga C, Arach B, Kenny J, Wavamunno P, Komunyena J, Kabamba D, Asiimwe AR, Mirembe G, Abongomera G, Mulenga V, Kekitiinwa A, Kityo C, Walker SA, Klein N, Gibb DM; CHAPAS-3 trial team.

Antivir Ther. 2014;19(3):269-76. doi: 10.3851/IMP2695. Epub 2013 Oct 25.

PMID:
24717427
[PubMed - in process]
2.

Is nevirapine dose-escalation appropriate in young, African, HIV-infected children?

Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Chintu C, Gibb DM, Walker AS, Burger DM; CHAPAS-1 trial team.

AIDS. 2013 Aug 24;27(13):2111-5. doi: 10.1097/QAD.0b013e3283620811.

PMID:
23595153
[PubMed - indexed for MEDLINE]
3.

The needs for HIV treatment and care of children, adolescents, pregnant women and older people in low-income and middle-income countries.

Kenny J, Mulenga V, Hoskins S, Scholten F, Gibb DM.

AIDS. 2012 Dec;26 Suppl 2:S105-16. doi: 10.1097/QAD.0b013e32835bddfc. Review.

PMID:
23303433
[PubMed - indexed for MEDLINE]
4.

Treatment of young children with HIV infection: using evidence to inform policymakers.

Prendergast AJ, Penazzato M, Cotton M, Musoke P, Mulenga V, Abrams EJ, Gibb DM.

PLoS Med. 2012;9(7):e1001273. doi: 10.1371/journal.pmed.1001273. Epub 2012 Jul 24. Review. No abstract available.

PMID:
22910874
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Pharmacokinetics of nevirapine in HIV-infected infants weighing 3 kg to less than 6 kg taking paediatric fixed dose combination tablets.

Fillekes Q, Mulenga V, Kabamba D, Kankasa C, Thomason MJ, Cook A, Ferrier A, Chintu C, Walker AS, Gibb DM, Burger DM.

AIDS. 2012 Sep 10;26(14):1795-800. doi: 10.1097/QAD.0b013e32835705fd.

PMID:
22739394
[PubMed - indexed for MEDLINE]
6.

Pharmacokinetics of nevirapine in HIV-infected children under 3 years on rifampicin-based antituberculosis treatment.

Oudijk JM, McIlleron H, Mulenga V, Chintu C, Merry C, Walker AS, Cook A, Gibb DM, Burger DM.

AIDS. 2012 Jul 31;26(12):1523-8. doi: 10.1097/QAD.0b013e3283550e20.

PMID:
22546991
[PubMed - indexed for MEDLINE]
7.

Diarrhea is a major killer of children with severe acute malnutrition admitted to inpatient set-up in Lusaka, Zambia.

Irena AH, Mwambazi M, Mulenga V.

Nutr J. 2011 Oct 11;10:110. doi: 10.1186/1475-2891-10-110.

PMID:
21989455
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

The evolution of HIV-1 reverse transcriptase in route to acquisition of Q151M multi-drug resistance is complex and involves mutations in multiple domains.

Mbisa JL, Gupta RK, Kabamba D, Mulenga V, Kalumbi M, Chintu C, Parry CM, Gibb DM, Walker SA, Cane PA, Pillay D.

Retrovirology. 2011 May 11;8:31. doi: 10.1186/1742-4690-8-31.

PMID:
21569325
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Excellent adherence to antiretrovirals in HIV+ Zambian children is compromised by disrupted routine, HIV nondisclosure, and paradoxical income effects.

Haberer JE, Cook A, Walker AS, Ngambi M, Ferrier A, Mulenga V, Kityo C, Thomason M, Kabamba D, Chintu C, Gibb DM, Bangsberg DR.

PLoS One. 2011 Apr 21;6(4):e18505. doi: 10.1371/journal.pone.0018505.

PMID:
21533031
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Improved growth and anemia in HIV-infected African children taking cotrimoxazole prophylaxis.

Prendergast A, Walker AS, Mulenga V, Chintu C, Gibb DM.

Clin Infect Dis. 2011 Apr 1;52(7):953-6. doi: 10.1093/cid/cir029.

PMID:
21427404
[PubMed - indexed for MEDLINE]
Free Article
11.

Strategies for nevirapine initiation in HIV-infected children taking pediatric fixed-dose combination "baby pills" in Zambia: a randomized controlled trial.

Mulenga V, Cook A, Walker AS, Kabamba D, Chijoka C, Ferrier A, Kalengo C, Kityo C, Kankasa C, Burger D, Thomason M, Chintu C, Gibb DM.

Clin Infect Dis. 2010 Nov 1;51(9):1081-9. doi: 10.1086/656628.

PMID:
20868279
[PubMed - indexed for MEDLINE]
Free Article
12.

Drug resistance in human immunodeficiency virus type-1 infected Zambian children using adult fixed dose combination stavudine, lamivudine, and nevirapine.

Gupta RK, Ford D, Mulenga V, Walker AS, Kabamba D, Kalumbi M, Grant PR, Ferrier A, Pillay D, Gibb DM, Chintu C.

Pediatr Infect Dis J. 2010 Aug;29(8):e57-62. doi: 10.1097/INF.0b013e3181e47609.

PMID:
20508547
[PubMed - indexed for MEDLINE]
13.

Limited sampling models to predict the pharmacokinetics of nevirapine, stavudine, and lamivudine in HIV-infected children treated with pediatric fixed-dose combination tablets.

Burger D, Ewings F, Kabamba D, L'homme R, Mulenga V, Kankasa C, Thomason M, Gibb DM, Chintu C, Walker AS.

Ther Drug Monit. 2010 Jun;32(3):369-72. doi: 10.1097/FTD.0b013e3181d75e47.

PMID:
20386361
[PubMed - indexed for MEDLINE]
14.

Performance of modified WHO presumptive criteria for diagnosis of HIV infection in children <18 months admitted to University Teaching Hospital in Lusaka.

Mutesu-Kapembwa K, Andrews B, Kapembwa K, Chi BH, Banda Y, Mulenga V, Kankasa C.

Med J Zambia. 2010;37(2):64-70.

PMID:
23170039
[PubMed]
Free PMC Article
15.

Adherence to both cotrimoxazole and placebo is associated with improved survival among HIV-infected Zambian children.

Walker AS, Ford D, Mulenga V, Thomason MJ, Nunn A, Chintu C, Gibb DM, Bangsberg DR.

AIDS Behav. 2009 Feb;13(1):33-41. doi: 10.1007/s10461-008-9382-4. Epub 2008 Apr 10.

PMID:
18401699
[PubMed - indexed for MEDLINE]
16.

The cost-effectiveness of cotrimoxazole prophylaxis in HIV-infected children in Zambia.

Ryan M, Griffin S, Chitah B, Walker AS, Mulenga V, Kalolo D, Hawkins N, Merry C, Barry MG, Chintu C, Sculpher MJ, Gibb DM.

AIDS. 2008 Mar 30;22(6):749-57. doi: 10.1097/QAD.0b013e3282f43519.

PMID:
18356605
[PubMed - indexed for MEDLINE]
17.

Nevirapine, stavudine and lamivudine pharmacokinetics in African children on paediatric fixed-dose combination tablets.

L'homme RF, Kabamba D, Ewings FM, Mulenga V, Kankasa C, Thomason MJ, Walker AS, Chintu C, Burger DM, Gibb DM.

AIDS. 2008 Mar 12;22(5):557-65. doi: 10.1097/QAD.0b013e3282f4a208.

PMID:
18316996
[PubMed - indexed for MEDLINE]
18.

Nevirapine concentrations in HIV-infected children treated with divided fixed-dose combination antiretroviral tablets in Malawi and Zambia.

Ellis JC, L'homme RF, Ewings FM, Mulenga V, Bell F, Chileshe R, Molyneux E, Abernethy J, van Oosterhout JJ, Chintu C, Walker AS, Gibb DM, Burger DM.

Antivir Ther. 2007;12(2):253-60.

PMID:
17503667
[PubMed - indexed for MEDLINE]
19.

The impact of daily cotrimoxazole prophylaxis and antiretroviral therapy on mortality and hospital admissions in HIV-infected Zambian children.

Walker AS, Mulenga V, Ford D, Kabamba D, Sinyinza F, Kankasa C, Chintu C, Gibb DM; CHAP Team.

Clin Infect Dis. 2007 May 15;44(10):1361-7. Epub 2007 Apr 12.

PMID:
17443476
[PubMed - indexed for MEDLINE]
Free Article
20.

Effect of cotrimoxazole on causes of death, hospital admissions and antibiotic use in HIV-infected children.

Mulenga V, Ford D, Walker AS, Mwenya D, Mwansa J, Sinyinza F, Lishimpi K, Nunn A, Gillespie S, Zumla A, Chintu C, Gibb DM; CHAP Trial Team.

AIDS. 2007 Jan 2;21(1):77-84.

PMID:
17148971
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk